SCHEMBL4411701

SCHEMBL4411701

O=C(NCc1ccncc1)c1ccno1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.59
ALDH1A1 P00352 3/20 0.59
ACE2 Q9BYF1 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.53
GAA P10253 2/20 0.53
MMP13 P45452 2/20 0.51
MAPK1 P28482 2/20 0.51
CYP3A4 P08684 2/20 0.50
MAPK14 Q16539 2/20 0.50
CA2 P00918 1/20 0.49
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
POLB P06746 1/20 0.48
ROCK2 O75116 1/20 0.48
RPS6KA5 O75582 1/20 0.48
MAP4K4 O95819 1/20 0.48
PRKCG P05129 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4418772 0.81 NPSR1 (0.63) ALDH1A1SMN1; SMN2GAAMMP13LMNA
SCHEMBL4439118 0.77 KEAP1 (0.51) HSD17B10ALDH1A1ACE2GAAMAPK1
SCHEMBL13702379 0.77 KMT2A (0.51) HSD17B10ALDH1A1ACE2GAAMAPK1
SCHEMBL1569157 0.77 L3MBTL1 (0.77) HSD17B10ALDH1A1L3MBTL1SMN1; SMN2GAA
SCHEMBL1570163 0.76 ACE2 (0.48) ALDH1A1ACE2SMN1; SMN2GAAKEAP1
SCHEMBL4417846 0.75 ALDH1A1 (0.66) ALDH1A1L3MBTL1SMN1; SMN2MAPK1MAPK14
SCHEMBL13101027 0.75 ACE2 (0.49) HSD17B10ALDH1A1ACE2GAAMAPK1
SCHEMBL12223956 0.75 POLB (0.57) ALDH1A1ACE2SMN1; SMN2GAAMAPK1
SCHEMBL159413 0.74
SCHEMBL22875492 0.74 ACE2 (1.00) ACE2L3MBTL1SMN1; SMN2GAAMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed